← back to search

Katherine B. Chiappinelli

George Washington University · US
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, RNA modifications and cancer, and Histone Deacetylase Inhibitors Research.
h-index
26
citations
7,225
works
291
NIH funding
primary concept
email

Recent publications

Activating antiviral immune responses potentiates immune checkpoint inhibition in glioblastoma models
Journal of Clinical Investigation 2025cited by 8position: middledoi
Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanoma
Journal of Experimental & Clinical Cancer Research 2024cited by 19position: middledoi
Oncogenic Transformation Drives DNA Methylation Loss and Transcriptional Activation at Transposable Element Loci
Cancer Research 2023cited by 27position: lastdoi
Priming a vascular-selective cytokine response permits CD8+ T-cell entry into tumors
Nature Communications 2023cited by 19position: middledoi
Locus-Specific Characterization of Human Endogenous Retrovirus Expression in Prostate, Breast, and Colon Cancers
Cancer Research 2021cited by 47position: middledoi
Abstract PR04: Tumor immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes
Clinical Cancer Research 2020cited by 0position: middledoi
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer
Cell 2017cited by 518position: middledoi
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Cell 2015cited by 1,973position: firstdoi
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Nature reviews. Cancer 2015cited by 1,416position: middledoi
Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
Oncotarget 2014cited by 439position: middledoi
Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer
Clinical Cancer Research 2013cited by 212position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Stephen B. Baylin · Evangelisches Diakoniekrankenhaus5 papers (2013–2023)Cynthia A. Zahnow · Johns Hopkins University3 papers (2014–2017)Pamela L. Strissel · University Hospital Heidelberg3 papers (2015–2020)Reiner Strick · University Hospital Heidelberg3 papers (2015–2020)Keith A. Crandall · George Washington University2 papers (2021–2023)Michael J. Topper · Johns Hopkins University2 papers (2014–2017)Matthew L. Bendall · Milken Institute2 papers (2021–2023)Drew M. Pardoll · Bloomberg (United States)2 papers (2014–2015)Huili Li · Johns Hopkins University2 papers (2014–2015)Ray-Whay Chiu Yen · Johns Hopkins University2 papers (2014–2017)Nita Ahuja · Johns Hopkins University2 papers (2013–2014)Dennis J. Slamon · APLA Health2 papers (2014–2015)Hariharan Easwaran · GTx (United States)2 papers (2014–2023)Angela A. Guzzetta · Southwestern Medical Center2 papers (2013–2014)Thomas Stefan Worst · Heidelberg University1 papers (2020–2020)Rohan Fernandes · University of Maryland, College Park1 papers (2024–2024) · 1 papers (2023–2023)Satish Noonepalle · University of Arizona1 papers (2024–2024)Christine A. Iacobuzio–Donahue · Pancreatic Cancer Action Network1 papers (2013–2013)Bastian Keck · Friedrich-Alexander-Universität Erlangen-Nürnberg1 papers (2020–2020)